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Introduction {#sec1}
============

CD4^+^ T cells are critical for defense against a wide array of invading microbes and pathogens but are also major drivers of autoimmune diseases. Based on their cytokine secretion profile and expression of specific transcription factors, CD4^+^ T cells can be classified into functionally different subsets, e.g., Th1, Th2, Th17, and regulatory T cells (Tregs) ([@bib37]). It was generally accepted that IFN-γ-expressing Th1 cells primarily initiate and perpetuate tissue damage in autoimmunity ([@bib34]). This paradigm was challenged in 2005 by the discovery of a highly pathogenic IL-17-producing CD4^+^ effector T cell subset, termed Th17 cells ([@bib16], [@bib39]). Th17 cells are characterized by their key transcription factors RORγt and STAT3 ([@bib21], [@bib36]), the production of the cytokines IL-17A, IL-17F, IL-22 and GM-CSF ([@bib9], [@bib58]), and high expression of CCR6 ([@bib1]). Today, their central role in the pathogenesis of several autoimmune diseases is clearly established ([@bib14]).

Crescentic glomerulonephritis (cGN) is the most aggressive form of autoimmune kidney diseases that destroys kidneys over a period of days to weeks, leading to end-stage renal failure with associated high morbidity, mortality, and public health costs ([@bib11], [@bib28]). The infiltration of leukocytes, including T cells, and the proliferation of resident glomerular cells lead to the formation of glomerular crescents and a disrupted anatomical structure of the glomerulus, ultimately leading to loss of kidney function. Current treatment protocols are unspecific and hampered by toxic side effects that deteriorate patient outcome.

Recent studies have highlighted the substantial impact of the Th17 immune response in cGN ([@bib25], [@bib28]). This includes the identification and characterization of CCR6^+^ IL-17-producing T cells in murine kidneys in experimental models of cGN ([@bib41], [@bib55]), as well as evidence for the contribution of IL-17A, IL-17F, IL-17RA, IL-23p19, and RORγt to renal tissue injury in cGN ([@bib40], [@bib45], [@bib46], [@bib50], [@bib51]). Th17-cell-derived IL-17A and IL-17F promote the expression of chemokines such as CXCL1 and CXCL5 in the kidney and thereby drive recruitment of neutrophils and other leukocyte subtypes, which mediate renal tissue destruction in cGN ([@bib12], [@bib55]). Although we are beginning to understand the effector functions of Th17 cells in the target tissue, the developmental origin of Th17 cells that infiltrate inflamed tissues, e.g., the kidney in glomerulonephritis, is still a matter of debate.

Under homeostatic conditions, Th17 cells are most abundant in the small intestinal lamina propria, and their presence in the gut of mice requires the colonization with specific adhesive microorganisms ([@bib23]). Colonization of mice with segmented filamentous bacteria (SFB) results in the generation of SFB-specific Th17 cells ([@bib57]). In addition to SFB, infection of mice with enterohemorrhagic *Escherichia coli* (EHEC) or *Citrobacter rodentium* results in the expansion of intestinal Th17 cells ([@bib5], [@bib23], [@bib47]). In line with this, germ-free mice lack intestinal Th17 cells, and antibiotic treatment of mice can reduce intestinal Th17 cell frequencies ([@bib4], [@bib22], [@bib44]). In addition, Th17 cells from lymphoid tissues preferentially home to the gut after transfer and are phenotypically almost indistinguishable from intestinal Th17 cells ([@bib18]). Th17 cells highly express CCR6, which orchestrates their trafficking to the small intestine ([@bib13]) but also to sites of peripheral inflammation, such as the kidney in glomerulonephritis ([@bib55]). Furthermore, organ-specific Th17 immune responses in experimental autoimmune encephalomyelitis (EAE) and arthritis are diminished in mice with reduced intestinal Th17 cells, i.e., in germ-free mice ([@bib29], [@bib56]). Taken together, these observations indicate a close relationship of Th17 cells with the intestinal microbiota. However, the mechanisms by which microbiota-induced Th17 cells promote extra-intestinal Th17 immune responses remain to be fully elucidated.

Here, using transgenic mice that ubiquitously express the photoconvertible Kaede-protein, we directly demonstrated the migration of intestinal Th17 cells to the kidney in experimental cGN. Experiments in microbiota-manipulated mice underscore the concept of pathogenic Th17 cells migrating from the gut to the inflamed kidney. Our findings provide evidence supporting a role for intestinal Th17 cells in the exacerbation of GN and suggest that migration of intestinal Th17 cells may contribute to pathology in other autoimmune diseases.

Results {#sec2}
=======

Identification and Characterization of Th17 Cells in the Kidneys of Patients with ANCA-Associated cGN {#sec2.1}
-----------------------------------------------------------------------------------------------------

Antineutrophil cytoplasmatic antibody (ANCA)-associated GN is the most common cause of cGN and is characterized by the formation of glomerular crescents ([Figure 1](#fig1){ref-type="fig"}A). This is associated with the infiltration of T cells and neutrophils ([Figure 1](#fig1){ref-type="fig"}B). To determine the composition of T cell subsets in ANCA-associated GN, we analyzed cells isolated from human renal biopsies by flow cytometry. The clinical characteristics of ANCA-GN patients included in this study are summarized in [Figure S1](#mmc1){ref-type="supplementary-material"}. Th17 cells can be distinguished from other CD4^+^ T cells via the expression of the transcription factor RORγt. We identified RORγt^+^ cells in the kidneys of patients with ANCA-associated GN ([Figures 1](#fig1){ref-type="fig"}C and 1D). The frequency of renal CD4^+^RORγt^+^ T cells was high (about 30%) and increased compared to CD4^+^ T cells from the peripheral blood (\<3%) of patients with ANCA-GN ([Figures 1](#fig1){ref-type="fig"}C--1E). In control kidney samples derived from tumor nephrectomies, CD4^+^RORγt^+^ cells were detected at low frequencies (\<3%, [Figures 1](#fig1){ref-type="fig"}E and 1F). RORγt expression by leukocytes isolated from inflamed kidneys was primarily allocated to CD3^+^ T cells (∼90%), and the majority of these were CD4^+^ T helper cells ([Figures 1](#fig1){ref-type="fig"}C and 1G). We recently reported increased expression of CCR6 and its ligand CCL20 in the kidney of patients with ANCA-GN ([@bib42]). In line with this finding, the majority of the CD4^+^RORγt^+^ Th17 cells in the kidney and blood expressed CCR6, supporting a role for this receptor in Th17 cell trafficking ([Figure 1](#fig1){ref-type="fig"}H).Figure 1Identification and Characterization of Th17 Cells in the Kidneys of Patients with ANCA-Associated cGN(A) PAS staining of a renal biopsy from a patient with ANCA-GN (glomerulus: dashed line; crescent: asterisked).(B) Consecutive tissue sections were stained for CD3 (T cells) and MPO (neutrophils).(C) Leukocytes from renal biopsies and peripheral blood samples from ANCA-GN patients were analyzed by flow cytometry.(D) CD3^+^CD4^+^ cells were analyzed for expression of RORγt and CCR6.(E) Quantification of RORγt^+^CCR6^+^ cells of all CD4^+^ T cells in kidney and blood (ANCA-GN) and control biopsies (unaffected renal tissue of explanted kidneys after tumor nephrectomy).(F) Flow cytometry of control biopsies (CD45^+^ cells).(G) Quantification of CD45^+^RORγt^+^ cells from the kidneys of patients with ANCA-GN as indicated.(H) CCR6 expression of RORγt^+^CD4^+^ T cells from the kidney and peripheral blood (ANCA-GN). Symbols represent individual data points with the mean as a horizontal line. Scale bar, 30 μm. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Renal Th17 Cells Have Gut-Homing Properties in Experimental cGN {#sec2.2}
---------------------------------------------------------------

To further investigate the function and trafficking properties of Th17 cells, we used the well-characterized mouse model of cGN ([@bib8], [@bib26], [@bib43], [@bib53]). The cGN model was induced by intraperitoneal (i.p.) injection of nephrotoxic sheep serum directed against the glomerular basement membrane (GBM). This prompted an adaptive immune response against the planted antigen, which resulted in the Th17-cell-dependent formation of glomerular crescents, tubulointerstitial injury, and loss of renal function ([Figure 2](#fig2){ref-type="fig"}A), resembling aspects of cGN in humans ([@bib26], [@bib40], [@bib50]). In this model, *Il17a* fate reporter mice (*Il17a*^Cre^ x *R26R*^eYFP^) were used to track Th17 cells ([@bib17]). CD4^+^ Th17 cells in the kidney increased at day 3--5, peaked around day 7--10 after GN induction, and then declined ([Figures 2](#fig2){ref-type="fig"}B and 2C). Importantly, fate-mapped eYFP^+^ Th17 cells almost uniformly expressed the signature cytokine IL-17A ([Figure 2](#fig2){ref-type="fig"}D), demonstrating the feasibility of this reporter system.Figure 2Renal Th17 Cells Have Gut-Homing Properties(A) PAS and CD3 staining of renal tissue sections of mice at day 10 after induction of crescentic glomerulonephritis (cGN). Scale bar, 20 μm.(B) Intracellular cytokine staining and FACS analyses of CD3^+^ T cells in the course of cGN (day 0--30).(C) Quantification of IL-17A^+^CD4^+^ Th17 cells in the course of cGN.(D) Flow cytometry of renal CD4^+^ T cells from *Il17a* fate reporter mice (*Il17a*^Cre^ × *R26R*^eYFP^) and intracellular staining for IL-17A expression.(E) CD44^high^ Th17 cells (YFP^+^) and CD44^high^ non-Th17 cells (YFP^−^) were FACS sorted from the kidneys of *Il17a* fate reporter mice with cGN. Cells were mixed in a 1:1 ratio and transferred into *Tcrα*^−*/*−^ recipients.(F and G) After 12 weeks, small intestinal lamina propria (SILP), mesenteric lymph nodes (mln), and inguinal lymph nodes (iln) were analyzed for the abundance of Th17 cells (YFP^+^) and non-Th17 cells (YFP^−^) by flow cytometry.(H) Transfer of FACS-sorted Th17 cells (CD44^high^YFP^+^) from the small intestine of *Il17a* fate reporter mice into *Tcrα*^−*/*−^ recipients and cGN induction 5 weeks after cell transfer. At day 8 after cGN induction, the kidneys were analyzed for gut-derived Th17 cells.(I and J) (I) PAS-stained kidney sections and (J) quantification of renal damage of mice after Th17 cell transfer and subsequent cGN induction.(K) cGN was induced in *Il17a* fate reporter mice. At day 10, renal Th17 cells (YFP^+^), renal non-Th17 cells (YFP^−^), and small-intestinal Th17 cells were FACS sorted and analyzed for TCRβ sequences using the ImmunoSEQ platform. Common sequences of intestinal Th17 and renal Th17 or renal non-Th17 cells were calculated. Error bars indicate SEM.See also [Figure S2](#mmc1){ref-type="supplementary-material"}. Data are representative of at least two independent experiments. Symbols represent individual data points with the mean as a horizontal line, bars represent mean values. ^∗^p \< 0.05, ^∗∗^p \< 0.01.

To evaluate the trafficking and homing properties of renal Th17 cells compared with other effector T cells, we sorted eYFP^+^ Th17 cells and eYFP^−^ CD4^+^ T cells with an activated phenotype (CD44^high^) from the kidney of nephritic *Il17a* fate reporter mice and co-transferred them at a 1:1 ratio into TCRα-deficient hosts lacking αβ^+^ T cells ([Figure 2](#fig2){ref-type="fig"}E). eYFP^+^ Th17 cells preferentially reconstituted (or were expanded in) the gut-associated tissues, such as the small intestinal lamina propria (SILP) and mesenteric lymph nodes, whereas eYFP^−^ CD44^high^ non-Th17 cells were preferentially found in peripheral lymph nodes ([Figures 2](#fig2){ref-type="fig"}F and 2G).

We next tested, vice versa, whether gut-derived Th17 cells are able to migrate to the kidney and, therefore, sorted small intestinal Th17 cells from *Il17a* fate reporter mice, transferred them into *Tcrα*^−/−^ animals and subsequently induced cGN. As shown in [Figure 2](#fig2){ref-type="fig"}H, gut-derived Th17 cells migrated to the kidney upon transfer. Moreover, they were sufficient to aggravate GN in T-cell-deficient animals ([Figures 2](#fig2){ref-type="fig"}I--2J).

To further examine the potential relationship of renal and intestinal Th17 cells, we analyzed the sequence of the CDR3 region of the *Tcrβ* gene of FACS-sorted eYFP^+^CD44^high^ cells (Th17) and eYFP^−^CD44^high^ cells (non-Th17) from the kidneys of nephritic *Il17a* fate reporter mice and compared those to intestinal Th17 cells sorted from the small intestine of the same mice, using the ImmunoSEQ platform. As shown in [Figures 2](#fig2){ref-type="fig"}K and [S2](#mmc1){ref-type="supplementary-material"}, renal Th17 cells shared more *Tcrβ* sequences with intestinal Th17 cells than with renal non-Th17 cells. Thus, gut and kidney Th17 cells might be reactive to identical antigens. However, further studies are clearly needed to characterize the antigen specificity of renal and gut Th17 in cGN. This is currently hampered by the lack of well-characterized CD4^+^ T cell epitopes in the cGN model.

Taken together, these data provide first evidence for the relationship of intestinal and renal Th17 cells and suggest the potential migration of Th17 cells from the small intestine into the kidney in crescentic glomerulonephritis.

Th17 Cells in Glomerulonephritis Migrate from the Intestine into the Kidney {#sec2.3}
---------------------------------------------------------------------------

To investigate the potential migration of T cells from the small intestine into the kidney in glomerulonephritis, we used mice engineered to ubiquitously express Kaede ([@bib52]). Kaede is a photoconvertible protein, which permanently changes its fluorescence emission from green (518 nm) to red (582 nm) upon photoactivation with near-UV light (350--410 nm). After selective exposure of the small intestine for 60 s, Kaede-photoconversion was specific to cells in the small intestine ([Figure S3](#mmc1){ref-type="supplementary-material"}).

Next, we induced cGN in *Kaede*-transgenic mice and photoconverted intestinal cells at day four ([Figure 3](#fig3){ref-type="fig"}A). At day seven, confocal microscopy of kidney sections revealed the presence of Kaede red^+^ cells in the tubulointerstitial area ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, migration of Kaede red^+^ cells into the inflamed kidney could be detected by flow cytometry, whereas under non-nephritic conditions, no significant migration of Kaede red^+^ cells was present ([Figures 3](#fig3){ref-type="fig"}C and 3D). Besides, intravascular staining using an anti-CD45 antibody 3 min before nephrectomy allowed the discrimination between tissue-localized and intravascular blood cells ([@bib2]) and demonstrated that Kaede red^+^ cell were indeed located within the inflamed kidney ([Figure S3](#mmc1){ref-type="supplementary-material"}), ruling out a contamination by circulating blood cells.Figure 3Th17 Cells in Glomerulonephritis Migrate from the Intestine into the Kidney(A) Experimental procedure: 4 days after cGN induction, photoconversion of the small intestine was performed, and at day 7, the kidneys were analyzed.(B) Confocal microscopy of Kaede red^+^ cells in a renal tissue section of *Kaede*-tg mice (nucleus: DRAQ5-staining, blue).(C) Flow cytometry of renal CD4^+^ T cells from *Kaede*-tg mice after cGN induction and photoconversion of the small intestine and controls. Kaede green^+^ cells and Kaede red^+^ cells were assessed for IL-17A and IFN-γ expression.(D) Quantification of IL-17A and IFN-γ expression in the respective Kaede population.(E and F) Analysis and quantification of IL-17A and IFN-γ expression in Kaede green^+^ and Kaede red^+^ γδ T cells. Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line.^∗^p \< 0.05, ^∗∗∗^p \< 0.001. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Most importantly, the percentage of IL-17A-positive cells was significantly higher in gut-derived Kaede red^+^ cells as compared to Kaede green^+^ cells ([Figures 3](#fig3){ref-type="fig"}C and 3D), demonstrating the preferential migration of Th17 cells from the intestine into the inflamed kidney. In contrast, IFN-γ-expressing Th1 cells were underrepresented in renal Kaede red^+^ cells ([Figure 3](#fig3){ref-type="fig"}D). There was also no accumulation of IL-17A-producing γδ T cells among Kaede red^+^ cells ([Figures 3](#fig3){ref-type="fig"}E and 3F), supporting the idea that γδ T cells reside in the target organ.

Th17 Cell Egress from the Small Intestine Is Dependent on S1P Receptor 1 {#sec2.4}
------------------------------------------------------------------------

The trafficking of Th17 cells from the intestine into the kidney requires the egress from the small intestinal lamina propria into the lymphatics. The mechanisms of T cell egress from extralymphoid tissue, in particular under inflammatory conditions, are poorly defined. It has been suggested that potential "exit receptors," such as CCR7 and the S1P receptor 1, might promote T cell egress, whereas "retention signals," e.g., CD103, might exert the opposite effect.

Flow cytometry of eYFP^+^ Th17 cells from the small intestine of nephritic *Il17a*^Cre^ × *R26R*^eYFP^ mice showed almost uniform surface expression of the activation marker CD44 and a high level of CD69 and CCR6 expression, whereas CD103 and CCR7 were hardly detectable ([Figures 4](#fig4){ref-type="fig"}A--4C). Due to the lack of suitable FACS antibodies for the S1P receptor 1, we sorted Th17 cells from the small intestine of nephritic and non-nephritic *Il17a* fate reporter mice and performed RT-PCR analysis. Interestingly, intestinal Th17 cells upregulated the mRNA expression of S1P receptor 1 and its major transcription factor KLF2 under nephritic conditions ([Figure 4](#fig4){ref-type="fig"}D), suggesting a potential function of this receptor for the egress of Th17 cells from the gut.Figure 4Th17 Cells Egress from the Intestine in a S1P-Receptor-1-Dependent Fashion and Migrate to the Kidney via the CCL20/CCR6 Axis in cGN(A--C) Flow cytometry of T cells from the small intestinal lamina propria of *Il17a* fate reporter mice for CD44, CD69, CCR6, CD103, and CCR7 as indicated.(D) RT-PCR analysis of FACS-sorting CD4^+^ Th17 cells from the small intestinal lamina propria of *Il17a* fate reporter mice. Error bars indicate SEM.(E) After cGN induction in *Kaede* control (±FTY720 treatment day 3--7) and *Kaede Ccr7*^−*/*−^ mice, intestinal cells were photoconverted and subsequently analyzed for Kaede red^+^ CD4^+^ T cells.(F--K) FACS analysis of intestinal (F and G), mesenteric lymph node (H), and renal (I--K) CD4^+^ T cells. See also [Figures S4](#mmc1){ref-type="supplementary-material"}A--S4D.(L) Renal Th17 cells from *Il17a* fate reporter mice at day 10 after cGN induction were analyzed for CCR6 expression by flow cytometry.(M) Quantitative RT-PCR of CCL20 and CCR6 in the kidneys of mice after induction of cGN and control mice (n = 4 per group). Error bars indicate SEM.(N and O) cGN was induced in *Kaede*-tg mice. From day 4 until 7, these mice received anti-CCL20 monoclonal antibody or isotype control. Photoconversion was performed at day 4. At day 7, renal CD4^+^ Kaede red^+^ T cells were analyzed for IL-17A and IFN-γ expression.See also [Figure S4](#mmc1){ref-type="supplementary-material"}E--S4G. Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line, bars represent mean values. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Consequently, we induced cGN in *Kaede*-transgenic mice, photoconverted intestinal cells at day four, and treated these mice from day four to seven with FTY720 ([Figure 4](#fig4){ref-type="fig"}E), a functional S1P receptor 1 agonist that arrests lymphocyte trafficking from lymphoid organs into systemic circulation. FTY720 treatment blocked the exit of CD4^+^ T cells from the small intestine ([Figures 4](#fig4){ref-type="fig"}F and 4G). Accordingly, the trafficking of Kaede red CD4^+^ T cells, including Th17 cells, from the intestine into the mesenteric lymph node ([Figure 4](#fig4){ref-type="fig"}H) and subsequently into the kidney was significantly reduced ([Figures 4](#fig4){ref-type="fig"}I--4K). In contrast, by using *Kaede Ccr7*^−/−^ mice, we demonstrated that the lack of *Ccr7* affected neither the emigration of CD4^+^ T cells out of the gut nor the migration of Th17 cells into the kidney ([Figures 4](#fig4){ref-type="fig"}F--4K). Taken together, these experiments revealed that Th17 cell egress from the small intestine is dependent on S1P receptor 1.

Of note, additional S1P receptor 1 blocking experiments demonstrated that the FTY720 application significantly reduced renal Th17 cell infiltration and subsequent kidney pathology in nephritic mice ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4D). These results further support---but due to the pleiotropic effect of FTY720, do not definitively confirm---the therapeutic potential of blocking Th17-cell gut egress in cGN.

CCR6/CCL20 Axis Guides the Trafficking of Intestinal Th17 into the Inflamed Kidney {#sec2.5}
----------------------------------------------------------------------------------

Following the exit from the gut, Th17 cells have to migrate via the circulation into the kidney. Th17 cells in the kidney highly express CCR6 ([Figures 4](#fig4){ref-type="fig"}L and 4M), which is accompanied by an upregulated expression of its unique ligand CCL20 in the inflamed kidney ([Figure 4](#fig4){ref-type="fig"}M). To find out whether the CCR6/CCL20 axis regulates the trafficking of intestinal Th17 into the kidney, nephritic *Kaede* mice were treated either with a neutralizing anti-CCL20 antibody or an isotype control antibody. The trafficking of photoconverted Th17 cells from the gut into the nephritic kidney was significantly reduced in mice treated with the anti-CCL20 antibody ([Figures 4](#fig4){ref-type="fig"}N and 4O). In contrast, Th1 cell recruitment was not affected ([Figure 4](#fig4){ref-type="fig"}N). Of note, anti-CCL20 treatment did not affect the emigration of CD4^+^ Th17 cells from the small intestine (data not shown). Moreover, CCL20 neutralization did not influence the clinical course of cGN ([Figures S4](#mmc1){ref-type="supplementary-material"}E--S4G). This is in line with a recent study demonstrating that the CCL20/CCR6 axis also mediates renal recruitment of Tregs, and that the reduction of anti-inflammatory Tregs in the presence of a fully functional Th1 response aggravates experimental glomerulonephritis ([@bib55]).

Renal Th17 Cell Responses and Tissue Injury in cGN Is Attenuated in Germ-Free Mice {#sec2.6}
----------------------------------------------------------------------------------

To evaluate the functional impact of intestinal Th17 cells on the course of Th17-driven experimental cGN, we induced glomerulonephritis in C57BL/6 mice raised and kept under germ-free (GF) or specific pathogen-free (SPF) conditions. The absence of microbiota in GF mice (GFM) resulted in a deficiency of intestinal Th17 cells ([Figure 5](#fig5){ref-type="fig"}A). Ten days after GN induction, Th17 cells were reduced in the kidneys of nephritic GFM, while the percentage of Th1 cells was unchanged ([Figures 5](#fig5){ref-type="fig"}B and 5C). In line, PAS-stained kidney sections revealed less glomerular and tubular damage in nephritic GFM compared to SPF mice ([Figures 5](#fig5){ref-type="fig"}D and 5E).Figure 5Renal Th17 Response in cGN Is Dependent on Intestinal Microbiota(A) Flow cytometry of CD4^+^ T cells from the small intestinal lamina propria of GFM and SPF mice after induction of cGN.(B and C) Flow cytometry of renal CD4^+^ T cells for IL-17A and IFN-γ expression.(D) PAS staining of renal cortex from cGN and control mice. Scale bar, 20 μm.(E) Glomerular crescent formation and tubulointerstitial damage (score) in the respective groups. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.(F--J) Mice were treated with a combination of 4 antibiotics (AMNV) for 4 weeks prior to induction of cGN. (F) Small intestinal CD4^+^ T cells and (G) renal CD4^+^ T cells were analyzed for IL-17A and IFN-γ. (H) Quantification of cytokine expression in renal CD4^+^ T cells. (I) PAS staining of renal cortex of mice with AMNV treatment and control mice. (J) Quantification of renal damage.See also [Figure S6](#mmc1){ref-type="supplementary-material"}. Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line. Scale bar, 20 μm. ^∗∗^p \< 0.01.

In contrast to the ameliorated course of GN in GFM, there was no difference in renal Th17 responses ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B) or renal tissue injury between nephritic mice and conventionally colonized ex-GFM ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

Depletion of the Gut Microbiota by Broad-Spectrum Antibiotics Ameliorates Th17 Cell Responses in cGN {#sec2.7}
----------------------------------------------------------------------------------------------------

To investigate whether the manipulation of gut microbiota in SPF mice might prevent Th17-promoted kidney damage, we orally treated mice with a cocktail of four antibiotics (ampicillin, metronidazole, neomycin, and vancomycin \[AMNV\]) prior cGN induction. In line with a recent report ([@bib19]), AMNV treatment almost depleted the gut microbiota ([Figure S6](#mmc1){ref-type="supplementary-material"}) and resulted in a reduced accumulation of Th17 cells in the small intestine ([Figure 5](#fig5){ref-type="fig"}F). Even more important, the number of renal Th17 cells ([Figures 5](#fig5){ref-type="fig"}G and 5H), but not Th1 cells, and the subsequent glomerular and tubulointerstitial injury were reduced ([Figures 5](#fig5){ref-type="fig"}I and 5J).

Expansion of Intestinal Th17 Cells in *Citrobacter*-*Rodentium*-Infected Mice Promotes Renal Th17 Responses in cGN {#sec2.8}
------------------------------------------------------------------------------------------------------------------

Next, we infected nephritic mice at day 0 with *Citrobacter rodentium* that triggers a potent Th17 cell response in the gut (predominantly in the colon and, to a lesser degree, in the small intestine) seven days after oral challenge ([Figure 6](#fig6){ref-type="fig"}A) ([@bib10]). Flow-cytometric analysis revealed that, indeed, the Th17 response was markedly upregulated in the kidneys of nephritic *C.*-*rodentium*-infected mice, while renal Th1 response and IL-17A production by γδ T cells were unchanged ([Figures 6](#fig6){ref-type="fig"}B and 6C). In accordance with the enhanced Th17 response, the recruitment of neutrophils into the kidney was increased ([Figure 6](#fig6){ref-type="fig"}D). Moreover, *C*.-*rodentium*-infected mice developed a moderately aggravated course of nephritis in terms of glomerular crescent formation and tubulointerstitial injury ([Figure 6](#fig6){ref-type="fig"}E).Figure 6Expansion of Intestinal Th17 Cells by *Citrobacter Rodentium* Infection Aggravates Renal Th17 Immune Responses in cGN(A) Flow cytometry of large intestine lamina propria CD4^+^ T cells after infection with *Citrobacter rodentium* and induction of cGN.(B and C) (B) Renal CD4^+^ T cells and (C) renal γδ T cells were analyzed for intracellular cytokine expression.(D) GR-1 staining and quantification of neutrophil infiltration in the renal cortex from mice with cGN.(E) Kidney damage was assessed by evaluation for glomerular crescents and tubulointerstitial damage in PAS-stained renal cortex sections. Scale bar, 25 μm.Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line.^∗^p \< 0.05, ^∗∗^p \< 0.01.

Therapeutic Manipulation of the Gut Microbiota with Vancomycin Reduces Th17-Cell-Driven Injury in cGN {#sec2.9}
-----------------------------------------------------------------------------------------------------

Finally, for a more specific therapeutic targeting of microbiota-induced Th17 cells in the gut, we treated mice orally with the glycopeptide antibiotic vancomycin (starting 4 weeks before GN induction). Vancomycin is not absorbed in the intestine, thus preventing major systemic side effects, and predominantly targets gram-positive bacteria, including Clostridia species. To analyze intestinal microbiota composition after vancomycin treatment, we applied amplicon sequencing. As expected, vancomycin treatment, in contrast to a combination of four antibiotics, which essentially eradicates the whole gut microbiome ([Figure S6](#mmc1){ref-type="supplementary-material"}), reduced the diversity of the intestinal microbiota without depleting all commensal bacteria ([Figures 7](#fig7){ref-type="fig"}A and 7B). In particular, the family Clostridiales (phylum Firmicutes), which has been previously shown to promote intestinal Th17 cells ([@bib23]), was reduced by this treatment. Furthermore, increased abundance of Enterobacteriaceae, Lactobacillaceae, and Verrucomicrobiaceae were detected ([Figure 7](#fig7){ref-type="fig"}B). Of note, segmented filamentous bacteria were not present.Figure 7Manipulation of the Gut Microbiota with Vancomycin Ameliorates Th17-Cell-Driven Injury in cGNMice were treated for 4 weeks with vancomycin via the drinking water prior to induction of cGN. At day 10, mice were sacrificed, and stool samples were analyzed by next-generation sequencing for microbiota abundance.(A) Alpha diversity of microbiota abundance in mice with cGN, with and without vancomycin treatment.(B) Abundance of bacteria on phylum level in mice after vancomycin treatment and control.(C) Intestinal CD4^+^ T cells from mice with and without vancomycin treatment were analyzed for cytokine production.(D and E) Quantification of IL-17A and IFN-γ in (D) intestinal CD4^+^ T cells and (E) renal CD4^+^ T cells after vancomycin treatment.(F and G) (F) GR-1 staining (scale bar, 50 μm) and (G) quantification of renal neutrophil infiltration.(H and I) (H) PAS staining (scale bar, 25 μm) and (I) quantification of renal tissue damage in mice after vancomycin treatment and induction of cGN.(J) BUN and albuminuria as functional parameters for kidney damage were measured in the respective groups. cGN induction was also assessed in vancomycin-treated *Il17a*^−*/*−^ mice.(K) Quantification of glomerular crescent formation and tubulointerstitial damage of nephritic *Il17a*^−*/*−^ mice ± vancomycin-treatment (scale bar, 25 μm).(L) BUN and albuminuria in *Il17a*^−*/*−^ ± vancomycin-treatment.(M) Quantification of renal neutrophil recruitment 10 days after nephritis induction.Data are representative of three independent experiments. Symbols represent individual data points, with the mean as a horizontal line. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Treatment with vancomycin was sufficient to selectively decrease the number of Th17 cells in the small intestine ([Figures 7](#fig7){ref-type="fig"}C and 7D). As seen in nephritic GFM and nephritic mice treated with broad-spectrum antibiotics, the diminished numbers of Th17 cells in the gut resulted in a reduced recruitment of Th17 cells, but not Th1 cells, into the kidney ([Figure 7](#fig7){ref-type="fig"}E). Vancomycin-treatment also reduced IL-17A expression by intestinal γδ T cells ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B) but did not affect IL-17A expression by renal γδ T cells in cGN ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7D). Accordingly, renal mRNA expression analysis, using a cytokine- and chemokine-pathway-focused PCR array (RT^2^ Profiler), revealed a predominant downregulation of Th17/IL-17A target genes in vancomycin-treated mice ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Subsequent RT-PCR analysis confirmed the reduced mRNA expression of the Th17 pathway, including the neutrophil chemoattractants CXCL1 and CXCL5 ([Figure S7](#mmc1){ref-type="supplementary-material"}F). In line, we observed decreased neutrophil recruitment into the kidney ([Figures 7](#fig7){ref-type="fig"}F and 7G). No major effect of vancomycin on the humoral immune response to the nephritogenic antigen was detectable ([Figures S7](#mmc1){ref-type="supplementary-material"}G--S7I). Vancomycin-treated animals developed less severe disease in terms of renal tissue injury ([Figures 7](#fig7){ref-type="fig"}H and 7I) and a better-preserved kidney function as measured by blood urea nitrogen (BUN) and albumin-to-creatinine ratio (ACR) ([Figure 7](#fig7){ref-type="fig"}J), highlighting the therapeutic potential of this approach. Of note, vancomycin application in nephritic *Il17a*^−/−^ mice had no effect on renal tissue injury or neutrophil recruitment ([Figures 7](#fig7){ref-type="fig"}K--7M), indicating that the ameliorated course of the disease in vancomycin-treated mice is indeed Th17/IL-17A-dependent.

Discussion {#sec3}
==========

Rapidly progressive or cGN is the most aggressive form of autoimmune kidney disease and remains a significant cause of end-stage renal failure. Different disease entities may lead to the development of cGN. The most common cause is ANCA-associated small vessel vasculitis ([@bib11], [@bib28]). Although there has been some progress in the treatment of patients with cGN, the use of unspecific immunosuppressive or cytotoxic agents is still recommended in guidelines, illustrating the fact that more specific treatment options based on the underlying immunopathogenic mechanisms are clearly needed.

There is convincing evidence for a pathogenic role of Th17 cells in murine models of crescentic and proliferative GN ([@bib15], [@bib20], [@bib26], [@bib38], [@bib41], [@bib40], [@bib43], [@bib45], [@bib50], [@bib54]), but the translation of these findings into new therapeutic approaches has been hindered by the lack of robust data about the role of the Th17 immune response in patients with cGN. Our flow cytometric analysis revealed that CD4^+^RORγt^+^ Th17 cell frequencies were up to 30% in the kidney of ANCA-GN patients, which is higher than the reported frequencies in most other tissues affected by autoimmune diseases ([@bib3]). The local Th17 cell response promotes kidney injury by recruiting neutrophils and other leukocyte subtypes to the target tissue in mice ([@bib12]), and its presence in human patients is a prerequisite for translating the findings gained from animal models into clinical practice, for example, as successfully done in IL-17A targeting for the treatment of psoriasis ([@bib30], [@bib32]).

The developmental origin of Th17 cells, promoting organ-specific autoimmunity, remains largely unexplored. Under homeostatic conditions, Th17 cells are most abundant in the gut, where their induction and accumulation depends on the gut microbiota ([@bib5], [@bib22], [@bib23], [@bib47]). Moreover, the induction of intestinal Th17 cells by commensal microbes, e.g., SFB, and the lack of Th17 cells in GFM, have profound effects on extra-intestinal autoimmune disorders ([@bib29], [@bib56]). This suggests a direct functional relationship between microbiota-induced Th17 cells in the gut and Th17-driven tissue injury at peripheral sites, e.g., the kidney.

To determine whether renal Th17 cells might be derived from the gut, we induced the Th17-cell-dependent model of cGN ([@bib8], [@bib26], [@bib43], [@bib53]) in photoconvertible *Kaede*-transgenic mice ([@bib52]). After photoconversion of cells in the small intestine, we were able to detect a significant proportion of gut-derived Th17 cells in the inflamed kidneys. Of note, due to technical limitations of the Kaede system that cannot be overcome at present (e.g., photoconversion in the small intestine was not \> 75%, did not include all segments of the gut, and covered only a short period of time), our finding did not provide final evidence that glomerulonephritis-driving Th17 cells are exclusively or predominantly derived from the gut. Using a related technical approach, [@bib33] demonstrate the movement of Th17 cells from the ascending colon into the spleen in arthritis-prone K/BxN mice, and [@bib31] reveal a constitutive trafficking of RORγt^+^ ILC3s from the intestine to the draining mesenteric lymph nodes. Recently, [@bib7] demonstrate that antibiotic-induced alterations in the intestinal flora reduce ischemic brain injury in mice, potentially as a consequence of a reduction in meningeal IL-17-positive γδ T cells. The authors use photoconvertible KiK mice to track cells from the gut, but they do not provide direct evidence for the migration of IL-17-producing cells (γδ T cells or CD4^+^ T cells) from the intestine to the CNS. In line with this report, we showed that targeting of the intestinal microbiota by vancomycin not only reduced IL-17-producing CD4^+^ T cells but also IL-17A-producing γδ T cells in the gut. However, in contrast to the study by [@bib7], these interventions did not influence IL-17A-producing γδ T cells at extra-intestinal sites, namely the inflamed kidney, supporting the idea that γδ T cells in cGN predominantly reside in the kidney and are not derived from the gut.

Our data provide direct evidence for the trafficking of Th17 cells from the gut to extra-intestinal sites of Th17-driven inflammation. The trafficking of Th17 cells from the intestine into the inflamed kidney in cGN required the exit from the small intestinal lamina propria into the lymphatics and, subsequently, via the circulation into the kidney. Effector T cells use S1P receptors to sense S1P gradients among blood, tissues, and lymph, thereby guiding entry into efferent lymphatics during egress from lymphoid tissues ([@bib6]); however, whether this concept also applies for non-lymphoid organs, e.g., the intestine, is less well characterized. Here, we found that Th17 cell egress from the small intestine was dependent on S1P receptor 1 and that their subsequent trafficking into the inflamed kidney was mediated via the CCL20/CCR6 axis.

Whether Th17 cells, generated in the intestine in response to microbes, represent a general "reservoir" for Th17 cells, which can be mobilized and migrate to distant sites of inflammation in autoimmune or infectious diseases, remains to be fully elucidated. Furthermore, it would be of great interest to study whether circulating Th17 cells from the gut are recruited primarily into the nephritic kidney via local chemoattractants or whether, in addition, so-far-unidentified kidney-derived signals might mobilize Th17 cells to exit the gut.

The absence of intestinal Th17 cells in GFM and their depletion in mice treated with broad-spectrum antibiotics resulted in a reduced renal Th17 response and ameliorated the consecutive tissue injury in glomerulonephritis. In contrast, expansion of intestinal Th17 cells in *Citrobacter*-*rodentium*-infected nephritic mice exerted the opposite effect. Most importantly, further experiments revealed that oral application of vancomycin alone was sufficient to reduce microbiota-induced intestinal Th17 cells and Th17 responses in the kidney, resulting in an ameliorated course of cGN without any significant side effects, emphasizing the great potential of this novel treatment strategy.

Before the manipulation of gut microbiota with, for example, antibiotics is tested as a therapeutic strategy in Th17-cell-driven human autoimmune disorders, a better understanding of the interaction of the microbiome and Th17 cells in the human intestine is clearly needed. But the finding that treatment with co-trimoxazole, given twice daily for 24 months, prevented relapses in patients with ANCA-associated vasculitis, in particular with upper respiratory disease ([@bib48]), is of interest. The mechanisms by which co-trimoxazole acts are still elusive, but it suggests a possible therapeutic role for antimicrobial therapy. Because this study was performed long before the first identification of Th17 cells, the effect of co-trimoxazole on gut microbiota and Th17 responses was not assessed.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

*Kaede*-transgenic mice were obtained from M. Tomura (Kyoto University) ([@bib52]). *Il17a*^*−/−*^ mice were provided by Y. Iwakura (University of Tokyo). *Ccr7*^*−/−*^ and *Tcrα*^*−/−*^ mice were from The Jackson Laboratory. *Il17a*^CRE^ × *R26R*^eYFP^ mice have previously been described ([@bib17]). Mice were on the C57BL/6J background and raised in SPF conditions. GFM were raised and kept under sterile conditions ([@bib49]). All animal experiments were approved by the local committees.

Animal Procedures {#sec4.2}
-----------------

Experimental cGN was induced by i.p. injection of nephrotoxic sheep serum in 8- to 12-week-old male mice ([@bib8], [@bib26], [@bib43], [@bib53]). For photoconversion, the small intestine of anesthetized *Kaede*-transgenic mice was subjected to lighting using a Blue Wave LED Prime UVA (Dymax). For urine analyses, mice were housed in metabolic cages for 5 hr, and urinary albumin was determined by ELISA (Bethyl Laboratories). For *Citrobacter rodentium* infections, mice were inoculated with 200 μL of a bacterial suspension (10^9^ CFU/mouse) via an oral gavage ([@bib35]).

Interventional Studies {#sec4.3}
----------------------

Mice were given either a combination of antibiotics (ampicillin 1 g/L, metronidazole 1 g/L, neomycin 1 g/L, and vancomycin 0.5 g/L) or vancomycin alone (0.5 g/L) by drinking water 4 weeks prior to the induction of cGN ([@bib22], [@bib44]). Anti-CCL20-antibody (clone 114908, R&D Systems) or isotype control (clone 43414, R&D Systems) were used at 50 μg/day per mouse (i.p.) at days 4, 5, and 6 after cGN induction ([@bib24]). FTY720 was added to the drinking water at 5 μg/mL ([@bib27]). FTY720 treatment was initiated 3 days after cGN induction and maintained until analysis.

Real-Time PCR Analyses {#sec4.4}
----------------------

Total RNA of the renal cortex was prepared according to standard laboratory methods. Real-time PCR was performed for 40 cycles on a StepOnePlus Real-Time PCR system (Applied Biosystems) as previously described ([@bib26]). All samples were run in duplicate and normalized to 18S rRNA.

Morphological Analyses {#sec4.5}
----------------------

Glomerular injury and crescent formation, deposition of PAS-positive material, and tubulointerstitial injury were assessed in PAS-stained renal tissue sections ([@bib26]). Further morphological analyses are described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Leukocyte Isolation and Transfer {#sec4.6}
--------------------------------

For T cell transfer experiments, CD4^+^ T cells were isolated from kidneys of *Il17a*^Cr*e*^ × *R26*^eYFP^ fate reporter mice at day 10 after induction of cGN or from the small intestine of these mice without cGN. Cells were sorted on a FACS Aria IIIa system ([@bib26]).

Flow Cytometry {#sec4.7}
--------------

Measurements were performed on a BD FACS LSR II or a BD LSR II Fortessa (BD Biosciences), and data were analyzed with the FlowJo (Tree Star). Cells were stained with antibodies from Biolegend, BD Biosciences, and eBioscience. LIVE/DEAD staining (Thermo Fisher) was used to exclude dead cells. For intracellular cytokine staining, cells were fixed and permeabilized using the Cytofix/Cytoperm kit (BD Bioscience) or 3.7% PFA/0.1% Igepal in the case of reporter mice ([@bib17]).

Analyses in Patients with ANCA-GN {#sec4.8}
---------------------------------

Single-cell suspensions were obtained from human biopsies by enzymatic digestion followed by dissociation with gentleMACS (Miltenyi Biotec), antibody staining, and flow cytometry ([@bib42]). Analyses of human kidney biopsies were approved by the local ethics committees (PV3162).

Sequencing Analysis {#sec4.9}
-------------------

TCR sequencing of FACS-sorted cells from *Il17a* fate reporter mice (*Il17a*^Cre^ × *R26R*^eYFP^) and 16S rRNA sequencing of murine feces is described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.10}
--------------------

Statistical analysis was performed using GraphPad Prism (La Jolla). The results are shown as the mean ± SEM when presented as a bar graph or as single data points with the mean in a scatter dot plot. Differences between two individual groups were compared using a two-tailed t test. In the case of three or more groups, a one-way ANOVA with Bonferroni's multiple comparisons test was used.

Authors Contributions {#sec5}
=====================

C.F.K., H.-J.P., S.K., T.K., U.S., and U.P. planned and performed experiments and analyses. C.F.K., J.-E.T., and U.P. designed the study and planned, as well as supervised, the research. C.F.K. and U.P. wrote the manuscript. S.R.B., J.-H.R., P. Bartsch, T.W., N.F., J.H., P. Busch, H.-W.M., B.S., R.A.K.S., C.M.-S., U.O.W., L.G.P., M.J., O.M.S., N.G., and S.H. performed experiments. C.F.K., J.-E.T., N.F., and U.P. analyzed the data and edited the manuscript.

Accession Numbers {#app1}
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